Drug Methadone

Posts Tagged ‘press release’

Drug Abuse Methadone: J&J Gets FDA Approval Of Potentially Addictive Opioid Nucynta – Medical News Today

ThirdAge

J&J Gets FDA Approval Of Potentially Addictive Opioid Nucynta Medical News Today In 1974, the Narcotic Addict Treatment Act allowed regulated methadone treatment for opioid addiction, but made off-label use of opioids illegal. Most recently in 2000, the Drug Addiction Treatment Act (DATA) allowed qualified physicians to use … NUCYNTA® ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for …MarketWatch (press release) all 33 news articles »

Drug Abuse Methadone – Google News

Find More Drug Abuse Methadone Information…

Drug Abuse Methadone: NUCYNTA® ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for … – MarketWatch (press release)

NUCYNTA® ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for … MarketWatch (press release) SmartMovesSmartChoices.org ) to increase awareness among educators, parents and teens about the serious problem of teen prescription drug abuse in the US To help ensure the risks of NUCYNTA® ER are communicated accurately, Janssen Pharmaceuticals, … and more »

Drug Abuse Methadone – Google News

More Drug Abuse Methadone Information…

Alcoholism Methadone: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge Eating Disorder Treatment
LONDON–(BUSINESSWIRE)– Lightlake Therapeutics Inc. (OTCBB: LLTP) (“Lightlake” or “the “Company”), an early stage biopharmaceutical company currently developing a nasal spray for the treatment of overweight …
Alcoholism Methadone – Yahoo! News Search Results

Alcoholism Methadone: Press Release
Lightlake Therapeutics Inc. Posted on:24 Aug 11 Dr. Roger Crystal, CEO of Lightlake commented, “We are excited to commence the definitive stage of testing of a product that we believe will be a solution to a disease thought to affect a significant proportion of obese and overweight patients today.
Alcoholism Methadone – Yahoo! News Search Results

Find More Alcoholism Methadone Information…

Alcoholism Methadone: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge … – MarketWatch (press release)

Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge … MarketWatch (press release) Lightlake recently acquired patents that will allow it to widen its product pipeline to address patients with addictions to opioid painkillers, methadone, cocaine and amphetamine. The Company anticipates launching a development program for each of … and more »

Alcoholism Methadone – Google News

Find More Alcoholism Methadone Information…

Drug Abuse Methadone: Cognitive functioning in opioid-dependent patients treatedwith buprenorphine … – 7thSpace Interactive (press release)

Cognitive functioning in opioid-dependent patients treatedwith buprenorphine … 7thSpace Interactive (press release) Correlations between cognitive functioning and medication, substance abuse, or demographic variables were then analyzed. Results: In part I methadone patients were inferior to healthy controls tests in all tests measuring attention, working memory, …

Drug Abuse Methadone – Google News

Related Drug Abuse Methadone Information…

Drug Abuse Methadone: Is Your Patient Abusing or Misusing? – MD News (press release)

Is Your Patient Abusing or Misusing? MD News (press release) In fact, between 1998 and 2006, the number of methadone prescriptions increased almost 700%. According to the Substance Abuse and Mental Health Services Administration, only 5- and 10-mg strength tables have been approved by the FDA for pain management …

Drug Abuse Methadone – Google News

Find More Drug Abuse Methadone Information…